Disclosure under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 received from Mr. Ravinder Gupta belongs to promoter group of the Company regarding sale of part ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Titan Biotech has disclosed that Mr. Ravinder Gupta, part of the promoter group, sold 1,000 equity shares of the company in the open market on September 19, 2025, at Rs. 955.08 per share, for a total value of Rs. 9.55 lakhs. This transaction was part of a trading plan that Mr. Gupta had earlier submitted to the stock exchange on August 5, 2024. After the sale, his shareholding in the company stands at 6,000 shares, or 0.073%, down from 7,000 shares (0.085%). The company clarified that the trading window was open at the time of the transaction, and the disclosure was filed under SEBI's insider trading regulations in Form C.
The sale is very small in size — a mere 0.012 percentage point reduction in promoter group holding — and follows a pre-declared trading plan, so it is unlikely to have any meaningful impact on the stock price or shareholder sentiment. This is a routine insider trading disclosure with no signal of broader promoter unloading.